2022 Q3 Form 10-Q Financial Statement

#000168316822005147 Filed on July 27, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $19.02K $41.44K $99.22K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $19.02K $41.44K $99.22K
YoY Change -24.22% -4.31%
Operating Profit -$19.02K -$41.44K
YoY Change -24.22% -4.31%
Interest Expense -$16.51K $0.00 -$24.10K
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$16.51K $0.00
YoY Change -102.46% -100.0%
Pretax Income -$35.53K -$41.44K $554.9K
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$35.53K -$41.44K $554.9K
YoY Change -105.5% -31.54%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $10.19K
COMMON SHARES
Basic Shares Outstanding 17.20M shares 34.77M shares
Diluted Shares Outstanding 17.20M shares 34.77M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $82.91K $97.07K
YoY Change
Cash & Equivalents $82.32K $95.34K $130.8K
Short-Term Investments
Other Short-Term Assets $132.5K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $82.91K $97.07K $132.5K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change
Goodwill
YoY Change
Intangibles $7.850K $23.23K $23.23K
YoY Change
Long-Term Investments
YoY Change
Other Assets $23.23K
YoY Change
Total Long-Term Assets $7.850K $23.23K $23.23K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $82.91K $97.07K $132.5K
Total Long-Term Assets $7.850K $23.23K $23.23K
Total Assets $90.76K $120.3K $155.7K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $44.99K $38.99K $32.99K
YoY Change -19.54%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $30.06K $30.06K $30.06K
YoY Change -95.72%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $75.05K $69.05K $63.05K
YoY Change -94.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $75.05K $69.05K $63.05K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $75.05K $69.05K $63.05K
YoY Change -94.32%
SHAREHOLDERS EQUITY
Retained Earnings -$640.7K -$605.1K -$563.7K
YoY Change
Common Stock $1.720K $1.720K $5.014K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.72K $51.25K $92.69K
YoY Change
Total Liabilities & Shareholders Equity $90.76K $120.3K $155.7K
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$35.53K -$41.44K $554.9K
YoY Change -105.5% -31.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$13.02K -$35.44K -$8.790K
YoY Change 1.82%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $0.00 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -13.02K -$35.44K -8.790K
Cash From Investing Activities 0.000 $0.00 0.000
Cash From Financing Activities 0.000 $0.00 0.000
Net Change In Cash -13.02K -$35.44K -8.790K
YoY Change -121.45%
FREE CASH FLOW
Cash From Operating Activities -$13.02K -$35.44K -$8.790K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001553264
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2022Q2 APSI Stock Cancelled During Period Value
StockCancelledDuringPeriodValue
usd
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
000-53554
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
AQUA POWER SYSTEMS INC.
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-4213903
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
2180 Park Avenue North
CY2022Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 200
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Winter Park
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32789
CY2022Q2 dei City Area Code
CityAreaCode
(407)
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
674-9444
CY2022Q2 dei Security12b Title
Security12bTitle
Common Stock , par $0.0001
CY2022Q2 dei Trading Symbol
TradingSymbol
APSI
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
23229 usd
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17204180 shares
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17204180 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17204180 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95339 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130778 usd
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50146804 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50146804 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1720 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
5014 usd
CY2022Q2 us-gaap Assets
Assets
120294 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
132504 usd
CY2022Q1 us-gaap Assets
Assets
155733 usd
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
38990 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23229 usd
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23229 usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
23229 usd
CY2022Q2 APSI Digital Currency
DigitalCurrency
1726 usd
CY2022Q1 APSI Digital Currency
DigitalCurrency
1726 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
97065 usd
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34773579 shares
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
32990 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
30055 usd
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
30055 usd
CY2022Q2 us-gaap Liabilities
Liabilities
69045 usd
CY2022Q1 us-gaap Liabilities
Liabilities
63045 usd
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
654170 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
650876 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-605141 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-563702 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
51249 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
92688 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120294 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
155733 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2021Q2 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
35439 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
37304 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
6000 usd
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
6000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
41439 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
43304 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-41439 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-43304 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
-0 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
17223 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
92688 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-41439 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
51249 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34773579 shares
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59143609 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-60527 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59143609 shares
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17223 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-41439 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1105397 usd
CY2022Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-41439 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
200000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-60527 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-965924 usd
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200000 usd
CY2021Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-60527 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6000 usd
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8500 usd
CY2022Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 usd
CY2021Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
17223 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35439 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34804 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
200000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-35439 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
165196 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130778 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95339 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165196 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q2 APSI Cancellation Of Shares
CancellationOfShares
3294 usd
CY2021Q2 APSI Cancellation Of Shares
CancellationOfShares
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-41439 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-605141 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35439 usd
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zSm5uhbFVxx1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p>
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2022Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2022Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0 usd
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 usd
CY2022Q2 us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
3
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000000 shares
CY2020Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
5100 usd
CY2022Q1 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
24955 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23229 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 APSI Preferred Stock Shares Designated
PreferredStockSharesDesignated
6000000 shares

Files In Submission

Name View Source Status
0001683168-22-005147-index-headers.html Edgar Link pending
0001683168-22-005147-index.html Edgar Link pending
0001683168-22-005147.txt Edgar Link pending
0001683168-22-005147-xbrl.zip Edgar Link pending
apsi-20220630.xsd Edgar Link pending
apsi-20220630_cal.xml Edgar Link unprocessable
apsi-20220630_def.xml Edgar Link unprocessable
apsi-20220630_lab.xml Edgar Link unprocessable
apsi-20220630_pre.xml Edgar Link unprocessable
aqua_ex3101.htm Edgar Link pending
aqua_ex3102.htm Edgar Link pending
aqua_ex3201.htm Edgar Link pending
aqua_i10q-063022.htm Edgar Link pending
aqua_i10q-063022_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending